Arovella Therapeutics Limited announced a private placement that it will issue 719,424 common shares to receive funding on July 4, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.165 AUD | +6.45% |
|
+17.86% | +43.48% |
04/07 | Arovella Therapeutics Limited announced a financing transaction | CI |
13/06 | Arovella Therapeutics, Teva Pharmaceuticals End ZolpiMist License Agreement | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+43.48% | 11Cr | |
+24.30% | 4.8TCr | |
+1.40% | 4.24TCr | |
+44.25% | 4.15TCr | |
+28.04% | 3.16TCr | |
+21.27% | 2.86TCr | |
-6.35% | 2.8TCr | |
+51.78% | 1.46TCr | |
+47.48% | 1.41TCr | |
+3.80% | 1.26TCr |
- Stock Market
- Equities
- ALA Stock
- News Arovella Therapeutics Limited
- Arovella Therapeutics Limited announced a financing transaction